Sharman John Stewart 4
4 · UNIVERSAL BIOSENSORS INC · Filed May 31, 2022
Insider Transaction Report
Form 4
Sharman John Stewart
Chief Executive Officer
Transactions
- Sale
Stock Option (Right to Buy)
2022-05-27$0.57/sh−1,000,000$570,000→ 0 total(indirect: By Spouse)Exercise: $0.20Exp: 2024-03-24→ Common Stock (1,000,000 underlying)
Holdings
- 2,364,667
Stock Option (Right to Buy)
Exercise: $0.25Exp: 2025-03-24→ Common Stock (2,364,667 underlying) - 276,217(indirect: By Spouse)
Common Stock
- 2,500,000
Performance Rights
Exp: 2025-03-24→ Common Stock (2,500,000 underlying) - 1,250,000
Performance Rights
Exp: 2025-03-24→ Common Stock (1,250,000 underlying) - 1,364,667
Stock Option (Right to Buy)
Exercise: $0.30Exp: 2025-03-24→ Common Stock (1,364,667 underlying) - 30,000
Common Stock
- 1,364,666
Stock Option (Right to Buy)
Exercise: $0.20Exp: 2024-03-24→ Common Stock (1,364,666 underlying) - 1,000,000(indirect: By superannuation fund)
Stock Option (Right to Buy)
Exercise: $0.30Exp: 2025-03-24→ Common Stock (1,000,000 underlying)
Footnotes (5)
- [F1]The reporting person disclaims beneficial ownership of the shares held by his wife, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.
- [F2]The price reported is stated in Australian dollars.
- [F3]The options are fully vested and became exercisable after September 24, 2020.
- [F4]Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
- [F5]Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.